Correlation of telomere length and telomerase activity with occult ovarian insufficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 4835-4843

  Butts, Samantha ^a   Riethman, Harold ^b   Ratcliffe, Sarah ^a   Shaunik, Alka ^a   Coutifaris, Christos ^a   Barnhart, Kurt ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPRORELIN; LUPROLIDE ACETATE; RECOMBINANT FOLLITROPIN; TELOMERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENUATION; CHROMOSOME ABERRATION; CHROMOSOME SIZE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GRANULOSA CELL; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY INSUFFICIENCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELOMERE;

EID: 73249150979     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2269     Document Type: Article

References (76)

1. Welt CK 2008 Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 68:499-509
2. Nelson LM 2009 Primary ovarian insufficiency. N Engl J Med 360:606-614
3. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott Jr RT 2001 Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 76:666-669
4. The Practice Committee of the American Society for Reproductive Medicine 2006 Age and infertility in women. Fertil Steril 86:S248-S252
5. Barnhart K, Osheroff J 1998 FSH as a predictor of fertility potential. Curr Opin Obstet Gynecol 10:227-232
6. Butts SF, Seifer DB 2009 6 office tests to assess ovarian reserve, and what they tell you. OBG Management 20:29-40
7. Bukulmez O, Arici A 2004 Assessment of ovarian reserve. Curr Opin Obstet Gynecol 16:231-237
8. Toner JP, Philput CB, Jones GS, Muasher SJ 1991 Basal follicle stimulating hormone level is a better predictor of in vitro fertilization outcome than age. Fertil Steril 55:784-791
9. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z 1988 The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 50:298-307
10. Centers for Disease Control and Prevention 2006 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
11. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE 2002Lownumber of retrieved oocytes at IVF treatment is predictive of early menopause. Fertil Steril 77:978-985
12. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, van Leeuwen FE 2003 Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18:1544-1552
13. Nikolaou D, Templeton A 2004 Early ovarian ageing. Eur J Obstet Gynecol Reprod Biol 113:126-133
14. Speroff L, Fritz M 2004 Clinical gynecologic endocrinology and infertility. 7th ed. Baltimore: Lippincott, Williams and Wilkins
15. Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal H 2002 Genetic disorders in premature ovarian failure. Hum Reprod Update 8:483-491
16. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G 2001 The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ ptosis/epicanthus inversus syndrome. Nat Genet 27:159-166
17. Fraser IS, Shearman RP, Smith A, Russell P 1988 An association between blepharophimosis, resistant ovary syndrome and true menopause. Fertil Steril 50:747-751
18. Sherman SL 2000 Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97:189-194
19. Lobo RA 2005 Potential options for preservation of fertility in women. N Engl J Med 353:64-73
20. Tulandi T, Huang JY, Tan SL 2008 Preservation of female fertility. Obstet Gynecol 112:1160-1172
21. Cramer DW, Harlow BL, Xu H, Fraer C, Barbieri R 1995 Cross-sectional and case controlled analysis of the association between smoking and early menopause. Maturitas 22:79-87
22. Paszkowski T, Clarke RN, Hornstein MD 2002 Smoking induces oxidative stress inside the graafian follicle. Hum Reprod 17:921-925
23. Baker TG 1963 A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 158:417-433
24. Gondos B, Bhiraleus P, Hobel CJ 1971 Ultrastructural observations on germ cells in human fetal ovaries. Am J Obstet Gynecol 110:644-652
25. The Committee on Gynecologic Practice of the American College of Obstetricians and Gynecologists and the Practice Committee of the American Society for Reproductive Medicine 2008 Age-related fertility decline: a committee opinion. Fertil Steril 90:S154-S155
26. Rolaki A, Drakakis P, Millingos S, Loutradis D, Makrigiannakis A 2005 Novel trends in follicular development, atresia and corpus luteum regression: a role for apoptosis. Reprod Biomed Online 11:93-103
27. Vaskivuo TE, Tapanainen JS 2003 Apoptosis in the human ovary. Reprod Biomed Online 6:24-35
28. ACOG Committee on Genetics 2006 Screening for fragile X syndrome. ACOG Committee Opinion No. 338. Obstet Gynecol 107:1483-1485
29. Sybert VP, McCauley E 2004 Turner's syndrome. N Engl J Med 351:1227-1238
30. de Lange T 2002 Protection of mammalian telomeres. Oncogene 21:532-540
31. Saldanha SN, Andrews LG, Tollefsbol TO 2003 Assessment of telomere length and factors that contribute to its stability. Eur J Biochem 270:389-403
32. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL,Wu JR 1988Ahighly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622-6626
33. Baird DM, Kipling D 2004 The extent and significance of telomere loss with age. Ann NY Acad Sci 1019:265-268
34. Fossel M 1998 Telomerase and the aging cell: implications for human health. JAMA 279:1732-1735
35. Buys CH 2000 Telomeres, telomerase and cancer. N Engl J Med 342:1282-1283
36. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, De Pinho RA 1999 p53 deficiency rescues the adverse effects of telomerase loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97:527-538
37. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T 1999 p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-1325
38. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO 1999 Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13:2388-2399
39. Harley CB, Futcher AB, Greider CW 1990 Telomeres shorten during ageing of human fibroblasts. Nature 354:458-460
40. Shawi M, Autexier C 2008 Telomerase, senescence and aging. Mech Ageing Dev 129:3-10
41. Hahn WC 2003 Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21:2034-2043
42. Flores I, Cayuela ML, Blasco MA 2005 Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309:1253-1256
43. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E, Artandi MK, Oro AE, Artandi SE 2005 Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436:1048-1052
44. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW 1994 Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
45. Wright DL, Jones EL, Mayer JF, Oehninger S, Gibbons WE, Lanzendorf SE 2001 Characterization of telomerase activity in the human oocyte and preimplantation embryo. Mol Hum Reprod 7:947-955
46. Liu L, Bailey SM, Okuka M, Muñoz P, Li C, Zhou L, Wu C, Czerwiec E, Sandler L, Seyfang A, Blasco MA, Keefe DL 2007 Telomere lengthening early in development. Nat Cell Biol 9:1436-1441
47. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW 1996 Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179
48. Lavranos TC, Mathis JM, Latham SE, Kalionis B, Shay JW, Rodgers RJ 1999 Evidence for ovarian granulosa stem cells: telomerase activity and localization of the telomerase RNA component in bovine ovarian follicles. Biol Reprod 61:358-366
49. Esposito MA, Coutifaris C, Barnhart KT 2002 A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women. Hum Reprod 17:118-123
50. Cawthon RM 2002 Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47
51. Getliffe KM, Al Dulaimi D, Martin-Ruiz C, Holder RL, von Zglinicki T, Morris A, Nwokolo CU 2005 Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking. Aliment Pharmacol Ther 21:121-131
52. Broberg K, Björk J, Paulsson K, Höglund M, Albin M 2005 Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 26:1263-1271
53. Martin-Ruiz C, Saretzki G, Petrie J, Ladhoff J, Jeyapalan J, Wei W, Sedivy J, von Zglinicki T 2004 Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span. J Biol Chem 279:17826-17833
54. Gil ME, Coetzer TL 2004 Real-time quantitative PCR of telomere length. Mol Biotechnol 27:169-172
55. Liu W, Zhu GJ 2003 Expression of telomerase in human ovarian luteinized granulosa cells and its relationship to ovarian function. Zhonghua Fu Chan Ke Za Zhi 38:402-404
56. Hanna CW, Bretherick KL, Gair JL, Fluker MR, Stephenson MD, Robinson WP 2009 Telomere length and reproductive aging. Hum Reprod 24:1206-1211
57. Aydos SE, Elhan AH, Tükün A 2005 Is telomere length one of the determinants of reproductive life span? Arch Gynecol Obstet 272:113-116
58. Seifer DB, Charland C, Berlinsky D, Penzias AS, Haning Jr RV, Naftolin F, Barker BE 1993 Proliferative index of human lutenized granulosa cells varies as a function of ovarian reserve. Am J Obstet Gynecol 169:1531-1535
59. Seifer DB, Gardiner AC, Ferreira KA, Peluso JJ 1996 Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization. Fertil Steril 66:593-598
60. Van Deerlin PG, Cekleniak N, Coutifaris C, Boyd J, Strauss 3rd JF 1997 Evidence for the oligoclonal origin of the granulosa cell population of the mature human follicle. J Clin Endocrinol Metab 82:3019-3024
61. Hofmann GE, Khoury J, Thie J 2000 Recurrent pregnancy loss and diminished ovarian reserve. Fertil Steril 74:1192-1195
62. Gürbüz B, Yalti S, Ozden S, Ficicioglu C 2004 High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet 270:37-39
63. Trout SW, Seifer DB 2000 Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril 74:335-337
64. Nasseri A, Mukherjee T, Grifo JA, Noyes N, Krey L, Copperman AB 1999 Elevated day 3 serum follicle stimulating hormone and/ orestradiol may predict fetal aneuploidy. Fertil Steril 71:715-718
65. Thum MY, Abdalla HI, Taylor D 2008 Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment. Fertil Steril 90:315-321
66. Weghofer A, Barad D, Li J, Gleicher N 2007 Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril 88:90-94
67. Massie JA, Burney RO, Milki AA, Westphal LM, Lathi RB 2008 Basal follicle stimulating hormone as a predictor of fetal aneuploidy. Fertil Steril 90:2351-2355
68. Yamamoto N, Christenson LK, McAllister JM, Strauss 3rd JF 2002 Growth differentiation factor-9 inhibits 3′ 5′-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab 87:2849-2856
69. Christenson LK, Stouffer RL, Strauss 3rd JF 2001 Quantitative analysis of the hormone-induced hyperacetylation of histone H3 associated with the steroidogenic acute regulatory protein gene promoter. J Biol Chem 276:27392-27399
70. Centers for Disease Control and Prevention 1999 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
71. Centers for Disease Control and Prevention 2000 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
72. Centers for Disease Control and Prevention 2001 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
73. Centers for Disease Control and Prevention 2002 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
74. Centers for Disease Control and Prevention 2003 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
75. Centers for Disease Control and Prevention 2004 Assisted Reproductive Technology (ART) Report. Atlanta: CDC
76. Centers for Disease Control and Prevention 2005 Assisted Reproductive Technology (ART) Report. Atlanta: CDC